The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
National Ankylosing Spondylitis Society
Unit 0.2, One Victoria Villas
Richmond Surrey, TW9 2GW
The National Ankylosing Spondylitis Society (NASS) is a voluntary, non-profit, self-help organization in the United Kingdom. The society, which was established in 1976 at the Royal National Hospital for Rheumatic Diseases in Bath, has approximately 100 chapters and 9,000 members. Ankylosing spondylitis is a chronic, progressive, inflammatory disease that usually initially affects the spine and adjacent areas, eventually causing fusion of involved joints. The National Ankylosing Spondylitis Society is committed to providing information and support to affected individuals and family members; offering a forum to educate medical professionals and the general public concerning AS; and supporting and funding research. The society also engages in patient advocacy; lobbies governmental bodies and the National Health Service to ensure the provision of better facilities for treatment; assists in the formation of similar societies in other countries; and forms branches across the United Kingdom that provide supervised exercise therapy sessions by physiotherapists.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.